Azithromycin in cystic fibrosis

Eur Respir J. 2005 Apr;25(4):771; author reply 771-2. doi: 10.1183/09031936.05.00129304.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / therapeutic use*
  • Cystic Fibrosis / complications*
  • Humans
  • Male
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Azithromycin